Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer named to CDLI for climate change efforts

Pfizer named to CDLI for climate change efforts

2nd October 2007

Pfizer has been named to the Climate Disclosure Leadership Index (CDLI) by the Carbon Disclosure Project (CDP), a mark of recognition for its efforts to improve the environment.

The firm reports that it is the sole pharmaceutical company named to the CDLI, being one of 68 Fortune 500 companies to be listed on the index.

Since 1996, Pfizer has implemented guidelines for the reduction of greenhouse gases and conservation of energy, with the firm becoming a charter member of the Climate Leaders Programme in 2002.

As such, the firm established a target of a 35 per cent reduction in CO2 emissions per million dollars of sales by the end of 2007 from 2000’s baseline figure.

The CDP is a non-profit body comprising of over 315 investors from around the world.

Steve Brooks, vice-president of global environment health and safety operations for Pfizer, said: “The advancement of good health occurs through the innovation, production and distribution of medicines, but also through the preservation of a healthy environment.”

He added that Pfizer has been able to conserve energy and increase efficiency through the hard work of its employees and energy teams, resulting in a reduction in its carbon footprint.

In March 2007, Pfizer was listed as one of the best companies for women’s business enterprises by the Women’s Business Enterprise National Council.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.